Clinical Study

The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases

Table 2

Patient characteristics and EGFR mutation status.

 NumberEGFR mutation ( 𝑛 , %) 𝑃 -value

Gender
 Male11217, 15.2% 𝑃 < 0 . 0 0 0 1
 Female8635, 40.7%
Age
 <658023, 28.8% 𝑃 = 0 . 5 1 5 6
 65≤11829, 24.6%
Histology
 Adenocarcinoma16950, 29.6% 𝑃 = 0 . 0 1 0 7
 Nonadenocarcinoma292, 6.9%
Smoking status
 Never7429, 39.2% 𝑃 = 0 . 0 1 3 9
 Ex/Current12423, 18.5%
Clinical stage of NSCLC
 I-IIIA6321, 33.3% 𝑃 = 0 . 1 6 4 9
 IIIB-IV13531, 22.9%
Chest CT
 Normal12243, 35.2% 𝑃 = 0 . 0 0 1 1
 Emphysema598, 13.6%
 Fibrosis171, 5.8%